Details of the Drug
General Information of Drug (ID: DMH9O6V)
Drug Name |
1-Cyclohexyl-3-phenethyl-urea
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-cyclohexyl-N'-(2-phenylethyl)urea; 1-cyclohexyl-3-phenethylurea; CHEMBL193888; MLS000061067; 1-Cyclohexyl-3-phenethyl-urea; AC1LEVP0; AC1Q5P4E; Cambridge id 5402894; Oprea1_499442; SCHEMBL12196137; CHEBI:108334; MolPort-001-839-964; ZINC182146; HMS2444C08; HMS1582O21; 1-cyclohexyl-3-(2-phenylethyl)urea; 3-cyclohexyl-1-(2-phenylethyl)urea; BDBM50167058; AKOS001026537; MCULE-2992993146; SMR000069580; US8815951, 36; AB00084095-01; Z44585920
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 246.35 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||